These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 3110674

  • 1. Acute responses of parathyroid hormone and 1,25 dihydroxyvitamin D3 to unilateral nephrectomy in healthy donors.
    Lucas PA, Brown RC, Woodhead JS.
    Nephrol Dial Transplant; 1986; 1(3):199-203. PubMed ID: 3110674
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
    Lucas PA, Woodhead JS, Brown RC.
    Nephrol Dial Transplant; 1988 Nov; 3(1):70-6. PubMed ID: 3132643
    [Abstract] [Full Text] [Related]

  • 4. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH, Roy L, Lepage R, Gascon-Barré M, D'Amour P.
    Miner Electrolyte Metab; 1997 Nov; 23(1):25-32. PubMed ID: 9058366
    [Abstract] [Full Text] [Related]

  • 5. Effect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy.
    McGonigle RJ, Weston MJ, Keenan J, Jackson DB, Parsons V.
    Magnesium; 1984 Nov; 3(1):1-7. PubMed ID: 6482508
    [Abstract] [Full Text] [Related]

  • 6. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K, Reinhardt D, Grosse-Hohmann E, Keck E.
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
    [Abstract] [Full Text] [Related]

  • 7. Regulation of parathyroid hormone and vitamin D in essential hypertension.
    Young EW, Morris CD, Holcomb S, McMillan G, McCarron DA.
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Absence of effect of 24,25-dihydroxycholecalciferol on serum immunoreactive PTH in patients with persistent hyperparathyroidism after renal transplantation.
    Friedlander MA, Horst RL, Hawker CD.
    Clin Nephrol; 1984 Oct; 22(4):206-10. PubMed ID: 6391769
    [Abstract] [Full Text] [Related]

  • 10. Do limited changes in phosphate intake modulate 1,25(OH)2D3 levels in early renal failure?
    Seidel A, Stein G, Schneider S, Schmidt-Gayk H, Ritz E.
    Clin Nephrol; 1991 Dec; 36(6):274-80. PubMed ID: 1769138
    [Abstract] [Full Text] [Related]

  • 11. Plasma parathyroid hormone, phosphatemia and vitamin D receptor genotype: are they interrelated?
    Chudek J, Karkoszka H, Schmidt-Gayk H, Ritz E, Kokot F.
    J Nephrol; 2000 Dec; 13(1):54-8. PubMed ID: 10720215
    [Abstract] [Full Text] [Related]

  • 12. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
    Portale AA, Booth BE, Halloran BP, Morris RC.
    J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
    [Abstract] [Full Text] [Related]

  • 13. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gordeladze JO, Lyngdal PT, Aarseth HP, Gautvik KM.
    Miner Electrolyte Metab; 1993 Jun; 19(2):78-85. PubMed ID: 8377728
    [Abstract] [Full Text] [Related]

  • 14. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B, Vestergaard P, Heickendorff L, Mosekilde L.
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
    [Abstract] [Full Text] [Related]

  • 15. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
    Alon U, Chan JC.
    J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
    [Abstract] [Full Text] [Related]

  • 16. Influence of serum phosphate on the efficacy of oral 1,25-dihydroxyvitamin D3 pulse therapy.
    Shoji S, Nishizawa Y, Tabata T, Emoto M, Morita A, Goto H, Ishimaura E, Inoue T, Inaba M, Miki T.
    Miner Electrolyte Metab; 1995 Apr; 21(1-3):223-8. PubMed ID: 7565454
    [Abstract] [Full Text] [Related]

  • 17. Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function.
    Akat K, Kaden JJ, Schmitz F, Ewering S, Anton A, Klomfass S, Hoffmann R, Ortlepp JR.
    Am J Cardiol; 2010 Mar 15; 105(6):862-4. PubMed ID: 20211333
    [Abstract] [Full Text] [Related]

  • 18. Inappropriate hypercalcitriolemia in ileum-resected patients with Crohn's disease.
    Rudnicki M, Frølich A, Transbøl I.
    Miner Electrolyte Metab; 1992 Mar 15; 18(1):52-5. PubMed ID: 1406505
    [Abstract] [Full Text] [Related]

  • 19. Renal mass and serum calcitriol in male idiopathic calcium renal stone formers: role of protein intake.
    Hess B, Ackermann D, Essig M, Takkinen R, Jaeger P.
    J Clin Endocrinol Metab; 1995 Jun 15; 80(6):1916-21. PubMed ID: 7775641
    [Abstract] [Full Text] [Related]

  • 20. Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure.
    Rudnicki M, McNair P, Transbøl I, Nielsen B.
    Nephron; 1991 Jun 15; 58(2):144-9. PubMed ID: 1865969
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.